Company intelligence / Profile preview

Trinity Delta

London, United Kingdomtrinitydelta.org ↗

Ownership: Private
Development stage: Other

Overview

Trinity Delta is the leading provider of issuer-paid equity research for the healthcare and life sciences sectors. The firm produces institutional-quality equity research on small- and mid-cap companies in biotech, medtech, specialty pharma, and consumer health. Their reports are made freely available to all investors under MiFID II regulations. They do not conduct execution business but focus solely on providing high-quality analysis to support investment decisions in the sector.

Industry: Consulting

Beyond the preview

Go deeper on Trinity Delta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trinity Delta.

Explore the full profile